INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,553,337 | +22.6% | 270,504 | +58.2% | 0.01% | +20.0% |
| Q2 2023 | $6,975,052 | +19.9% | 171,041 | +9.6% | 0.01% | +25.0% |
| Q1 2023 | $5,817,400 | +68.2% | 156,088 | +57.5% | 0.00% | +33.3% |
| Q4 2022 | $3,458,332 | -62.9% | 99,121 | -40.6% | 0.00% | -57.1% |
| Q3 2022 | $9,334,000 | +77.7% | 166,802 | +64.3% | 0.01% | +75.0% |
| Q2 2022 | $5,253,000 | -78.7% | 101,495 | -70.0% | 0.00% | -73.3% |
| Q1 2022 | $24,620,000 | +217.0% | 338,786 | +415.8% | 0.02% | +275.0% |
| Q4 2021 | $7,766,000 | -19.6% | 65,679 | -8.8% | 0.00% | -33.3% |
| Q3 2021 | $9,665,000 | -10.7% | 72,052 | +7.8% | 0.01% | -14.3% |
| Q2 2021 | $10,818,000 | +81.4% | 66,813 | -10.1% | 0.01% | +75.0% |
| Q1 2021 | $5,962,000 | +586.9% | 74,290 | +366.3% | 0.00% | +300.0% |
| Q4 2020 | $868,000 | +71.5% | 15,932 | -37.4% | 0.00% | – |
| Q3 2020 | $506,000 | -41.0% | 25,461 | -37.5% | 0.00% | -100.0% |
| Q2 2020 | $857,000 | +33.9% | 40,756 | -22.2% | 0.00% | – |
| Q1 2020 | $640,000 | -53.9% | 52,359 | -44.6% | 0.00% | -100.0% |
| Q4 2019 | $1,387,000 | -18.7% | 94,526 | -26.0% | 0.00% | 0.0% |
| Q3 2019 | $1,706,000 | +53.8% | 127,722 | +88.6% | 0.00% | 0.0% |
| Q2 2019 | $1,109,000 | +63.8% | 67,735 | +70.6% | 0.00% | 0.0% |
| Q1 2019 | $677,000 | -82.7% | 39,694 | -86.2% | 0.00% | -75.0% |
| Q4 2018 | $3,913,000 | -23.3% | 286,629 | +60.7% | 0.00% | -20.0% |
| Q3 2018 | $5,105,000 | +54.7% | 178,354 | +47.9% | 0.01% | +66.7% |
| Q2 2018 | $3,300,000 | +181.6% | 120,622 | +117.0% | 0.00% | +200.0% |
| Q1 2018 | $1,172,000 | +24.8% | 55,576 | +13.7% | 0.00% | 0.0% |
| Q4 2017 | $939,000 | +46850.0% | 48,882 | +32059.2% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 152 | +114.1% | 0.00% | – |
| Q1 2017 | $1,000 | – | 71 | +1320.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 5 | -99.1% | 0.00% | – |
| Q3 2016 | $10,000 | -33.3% | 573 | -18.5% | 0.00% | – |
| Q2 2016 | $15,000 | – | 703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |